Figure 6. RNAi of KinesinCaaX show enhanced sensitivity to protein farnesyl transferase inhibitors but not other drugs.
(A) LN-59 (B) DFMO and (C) Pentamidine mean % growth (normalized to no drug) in induced and noninduced KinesinCaaX RNAi cells. (D) LN-59 (E) DFMO and (F) Pentamidine mean % growth in induced and noninduced GSK RNAi line. Values normalized to no drug with error bars representing SD.